货号：UP608516665
| 产品信息 | |
| 产品名称： | Pluripotin |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 839707-37-8 |
| 分子式： | C27H25F3N8O2 |
| 分子量： | 550.54 |
| MDL NO： | - |
| 标准纯度： | 98+% (UP608516665) |
| 沸点： | - |
| 储存： | (UP608516665) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
AHU-377 Hemicalcium
UP4085967181369773-39-6
2-deoxy-D-Glucose
UP225160710154-17-6
1,3-Dichloro-5-(trifluoromethyl)benzene
UP53344270554773-20-5
Lasofoxifene Tartrate
UP458450971190791-29-8
Histamine Dihydrochloride
UP13583264056-92-8
GNF-8625
UP8503235261196546-33-4
PKC412
UP373819596120685-11-2
LY2090314
UP776296325603288-22-8
Vandetanib
UP138794460443913-73-3
GSK2606414
UP2584735961337531-36-8
PF-477736
UP299914781952021-60-2
GSK2245035 Maleate
UP5964942961325212-97-2
3-Phenylisothiazol-5-amine
UP77967084514208-52-7
DB07268
UP538744494929007-72-7
Divalproex Sodium
UP65196342276584-70-8
PF-543 Citrate
UP3808949251415562-83-2
AMD-070
UP675508776558447-26-0
DREADD agonist 21
UP20669228156296-18-5
CGP-57380
UP817867845522629-08-9
IDO-IN-6
UP1554800601402837-76-6
GLPG1690
UP4552943521628260-79-6
Regorafenib HCl
UP839392593835621-07-3
VTP-27999
UP155610902942142-51-0
N-Phenyl-5,6-dihydro-4H-1,3-thiazin-2-amine
UP7598032983420-40-4
Cytarabine hydrochloride
UP13266449269-74-9
Salermide
UP8098154401105698-15-4
Methyl 6-bromo-2-naphthoate
UP91255952933626-98-1
AZD8055
UP6061108411009298-09-2
CGP 37849
UP295801418127910-31-0
2-Methyl-1H-imidazo[4,5-b]pyridine
UP73326790268175-07-5
1,2-Di-p-tolyldiazene
UP227388535501-60-0
alpha-Spinasterol
UP418546192481-18-5
2-Bromo-4-nitrotoluene
UP3595528437745-93-9
Nastorazepide
UP865674726209219-38-5
Cinnoline
UP873234496253-66-7
5-Azacytidine
UP473310310320-67-2
VX-702
UP306585437745833-23-2
TCS 359
UP223036483301305-73-7
1-[2-(Benzyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-quinuclidinium Bromide
UP833085687869113-09-7
eFT508
UP7409151241849590-01-7
Emodin
UP958154664518-82-1
Ophiopogonin D
UP492686941945619-74-9
SRT1720
UP341945953925434-55-5
Gliclazide
UP75441803221187-98-4
SHP099 hydrochloride
UP4447479471801747-11-4
1-(Chloromethyl)-4-(methylsulfonyl)-2-(trifluoromethyl)benzene
UP4675649571086389-83-4
Captopril
UP58426076762571-86-2
SR-9243
UP4109682751613028-81-1
2-Acetylhydrazinecarbothioamide
UP6815306512302-88-7
FR 180204
UP472973708865362-74-9
Cetilistat
UP712439682282526-98-1
GDC-0994
UP5967482991453848-26-4
5-bromo-2-oxo-1H-pyridine-3-carbonitrile
UP7828233027405224-22-8
1,3-Bis(4,5-dihydrooxazol-2-yl)benzene
UP83009622634052-90-9
Losartan
UP285336737114798-26-4
LY2784544
UP8632234231229236-86-5
2,2'-(Methylazanediyl)diacetic acid
UP6571757404408-64-4
Y15
UP6267012124506-66-5
UM729
UP4296970811448723-60-1
3,3-Bis(2-methyl-1-octyl-1H-indol-3-yl)isobenzofuran-1(3H)-one
UP52717022650292-95-0
CYM 5541
UP291076450945128-26-7
2-(Methylthio)oxazole
UP250886400201017-90-5
FGF401
UP2649003691708971-55-4
K-Ras G12C-IN-1
UP9476357621629265-17-3
3-(2H-1,2,3-Triazol-4-yl)benzonitrile
UP236951730550364-01-7
Balicatib
UP146743346354813-19-7
N-(4-(5-Mercapto-1,3,4-oxadiazol-2-yl)phenyl)hydrazinecarbothioamide
UP617549423317337-07-8
Dabigatran etexilate mesylate
UP765972946872728-81-9
Methyl 3-oxobutanoate
UP864210545105-45-3
Pluripotin
UP608516665839707-37-8